A carregar...
Fingolimod in a patient with heart failure on the background of pulmonary arterial hypertension and coronary artery disease
BACKGROUND: Fingolimod is the first oral immunomodulatory therapy approved for highly active relapsing remitting multiple sclerosis. Based on the distribution pattern of fingolimod interacting sphingosine-1-phosphat receptors in organism including immune system and cardiovascular system clinical mon...
Na minha lista:
| Main Authors: | , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
BioMed Central
2014
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4055797/ https://ncbi.nlm.nih.gov/pubmed/24906818 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1471-2377-14-126 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|